Literature DB >> 18773134

Incidence rate and risk factors for vaginal vault prolapse repair after hysterectomy.

Patrick Dällenbach1, Isabelle Kaelin-Gambirasio, Sandrine Jacob, Jean-Bernard Dubuisson, Michel Boulvain.   

Abstract

Our objective was to estimate the incidence and identify the risk factors for vaginal vault prolapse repair after hysterectomy. We conducted a case control study among 6,214 women who underwent hysterectomy from 1982 to 2002. Cases (n = 32) were women who required vaginal vault suspension following the hysterectomy through December 2005. Controls (n = 236) were women, randomly selected from the same cohort, who did not require pelvic organ prolapse surgery. The incidence of vaginal vault prolapse repair was 0.36 per 1,000 women-years. The cumulative incidence was 0.5%. Risk factors included preoperative prolapse (odds ratio (OR) 6.6; 95% confidence interval (CI) 1.5-28.4) and sexual activity (OR 1.3; 95% CI 1.0-1.5). Vaginal hysterectomy was not a risk factor when preoperative prolapse was taken into account (OR 0.9; 95% CI 0.5-1.8).Vaginal vault prolapse repair after hysterectomy is an infrequent event and is due to preexisting weakness of pelvic tissues.

Entities:  

Mesh:

Year:  2008        PMID: 18773134     DOI: 10.1007/s00192-008-0718-4

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  17 in total

1.  Epidemiologic evaluation of reoperation for surgically treated pelvic organ prolapse and urinary incontinence.

Authors:  Amanda L Clark; Thomas Gregory; Virginia J Smith; Renee Edwards
Journal:  Am J Obstet Gynecol       Date:  2003-11       Impact factor: 8.661

2.  Vaginal prolapse following hysterectomy.

Authors:  R E SYMMONDS; J H PRATT
Journal:  Am J Obstet Gynecol       Date:  1960-05       Impact factor: 8.661

3.  Pelvic organ descent in young nulligravid women.

Authors:  H P Dietz; A Eldridge; M Grace; B Clarke
Journal:  Am J Obstet Gynecol       Date:  2004-07       Impact factor: 8.661

4.  Epidemiology of genital prolapse: observations from the Oxford Family Planning Association Study.

Authors:  J Mant; R Painter; M Vessey
Journal:  Br J Obstet Gynaecol       Date:  1997-05

Review 5.  Posthysterectomy vault prolapse.

Authors:  J W Barrington; G Edwards
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2000

6.  The distribution of pelvic organ support in a population of female subjects seen for routine gynecologic health care.

Authors:  S E Swift
Journal:  Am J Obstet Gynecol       Date:  2000-08       Impact factor: 8.661

7.  Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence.

Authors:  A L Olsen; V J Smith; J O Bergstrom; J C Colling; A L Clark
Journal:  Obstet Gynecol       Date:  1997-04       Impact factor: 7.661

8.  Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects.

Authors:  Steven Swift; Patrick Woodman; Amy O'Boyle; Margie Kahn; Michael Valley; Deirdre Bland; Wei Wang; Joe Schaffer
Journal:  Am J Obstet Gynecol       Date:  2005-03       Impact factor: 8.661

9.  Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors.

Authors:  E C Samuelsson; F T Victor; G Tibblin; K F Svärdsudd
Journal:  Am J Obstet Gynecol       Date:  1999-02       Impact factor: 8.661

10.  Sacrospinous ligament fixation at the time of transvaginal hysterectomy.

Authors:  S H Cruikshank; D W Cox
Journal:  Am J Obstet Gynecol       Date:  1990-06       Impact factor: 8.661

View more
  25 in total

1.  Laparoscopic sacrospinous ligament fixation for uterovaginal prolapse: experience with 93 cases.

Authors:  Yanzhou Wang; Dan Wang; Yuyan Li; Zhiqing Liang; Huicheng Xu
Journal:  Int Urogynecol J       Date:  2010-08-26       Impact factor: 2.894

2.  Comparison of the Efficiency of Posterior Intravaginal Sling (PIVS) Procedure in Older and Younger Groups.

Authors:  Tolgay Tuyan Ilhan; Akin Sivaslioglu; Türkan Ilhan; Mustafa Gazi Uçar; İsmail Dolen
Journal:  J Clin Diagn Res       Date:  2016-07-01

3.  An estimation of the frequency of surgery for posthysterectomy vault prolapse.

Authors:  Thomas Aigmueller; Andrea Dungl; Susanne Hinterholzer; Ingrid Geiss; Paul Riss
Journal:  Int Urogynecol J       Date:  2010-03       Impact factor: 2.894

4.  The indication for hysterectomy as a risk factor for subsequent pelvic organ prolapse repair.

Authors:  Rune Lykke; Jan Blaakær; Bent Ottesen; Helga Gimbel
Journal:  Int Urogynecol J       Date:  2015-06-07       Impact factor: 2.894

5.  Treatment of vaginal vault prolapse in The Netherlands: a clinical practice survey.

Authors:  Carolien K M Vermeulen; Anne Lotte W M Coolen; Wilbert A Spaans; Jan Paul W R Roovers; Marlies Y Bongers
Journal:  Int Urogynecol J       Date:  2018-12-04       Impact factor: 2.894

6.  The challenge of implementing laparoscopic sacrocolpopexy.

Authors:  Jan Deprest; Ladislav Krofta; Frank Van der Aa; Alfredo L Milani; Jan Den Boon; Filip Claerhout; Jan-Paul Roovers
Journal:  Int Urogynecol J       Date:  2014-05-21       Impact factor: 2.894

7.  Automated contour tracking and trajectory classification of pelvic organs on dynamic MRI.

Authors:  Iman Nekooeimehr; Susana Lai-Yuen; Paul Bao; Alfredo Weitzenfeld; Stuart Hart
Journal:  J Med Imaging (Bellingham)       Date:  2018-03-30

8.  Laparoscopic hysteropexy versus vaginal hysterectomy for the treatment of uterovaginal prolapse: a prospective randomized pilot study.

Authors:  Philip Rahmanou; Natalia Price; Simon R Jackson
Journal:  Int Urogynecol J       Date:  2015-07-04       Impact factor: 2.894

9.  Pelvic organ prolapse (POP) surgery among Danish women hysterectomized for benign conditions: age at hysterectomy, age at subsequent POP operation, and risk of POP after hysterectomy.

Authors:  Rune Lykke; Jan Blaakær; Bent Ottesen; Helga Gimbel
Journal:  Int Urogynecol J       Date:  2014-09-03       Impact factor: 2.894

10.  Assessment of a semiautomated pelvic floor measurement model for evaluating pelvic organ prolapse on MRI.

Authors:  S Onal; S Lai-Yuen; P Bao; A Weitzenfeld; K Greene; R Kedar; S Hart
Journal:  Int Urogynecol J       Date:  2014-01-16       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.